Table 1.
Surveillance variable (abbreviation) | Description | Definition |
ILIa diagnosis codes [32] (TMUHcSb-ILI) | Patients who were diagnosed with ILI-related symptoms | ILI diagnosis codes: (1) ICD-9-CMc codes: 480.xx~487.xx.; (2) ICD-10-CM codesd: J09-~J18-, A22-, A37-, B25-, and B44- |
Rapid influenza laboratory tests with positive results (TMUHcS-RITPe) | Patients who had positive results on rapid influenza tests based on ILI diagnosis codes | Rapid Influenza laboratory tests: positive, + And ILI diagnosis codes: (1) ICD-9-CM codes: 480.xx~487.xx (2) ICD-10-CM codesd: J09-~J18-, A22-, A37-, B25-, and B44- |
Influenza medication use (TMUHcS-IMUf) | Patients who were prescribed with antiviral drugs against influenza based on ILI diagnosis codes | Medications: Tamiflu, Relenza, Rapiacta, and Avigan And ILI diagnosis codes: (1) ICD-9-CM codes: 480.xx-487.xx (2) ICD-10-CM codesd: J09- to J18-, A22-, A37-, B25-, and B44- |
aILI: influenza-like illness.
bTMUHcS: Taipei Medical University Health Care System.
cICD-9-CM: International Classification of Disease, Ninth Revision, Clinical Modification.
dImplemented in Taiwan in January 2016.
eRITP: rapid influenza laboratory tests with positive results.
fIMU: influenza medication use.